Anavex Life Sciences (AVXL) Competitors $7.78 +0.25 (+3.32%) Closing price 04:00 PM EasternExtended Trading$7.69 -0.09 (-1.11%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AVXL vs. CPRX, MOR, PTGX, MTSR, XENE, MLTX, IMVT, HCM, AMRX, and OGNShould you be buying Anavex Life Sciences stock or one of its competitors? The main competitors of Anavex Life Sciences include Catalyst Pharmaceuticals (CPRX), MorphoSys (MOR), Protagonist Therapeutics (PTGX), Metsera (MTSR), Xenon Pharmaceuticals (XENE), MoonLake Immunotherapeutics (MLTX), Immunovant (IMVT), HUTCHMED (HCM), Amneal Pharmaceuticals (AMRX), and Organon & Co. (OGN). These companies are all part of the "pharmaceutical products" industry. Anavex Life Sciences vs. Catalyst Pharmaceuticals MorphoSys Protagonist Therapeutics Metsera Xenon Pharmaceuticals MoonLake Immunotherapeutics Immunovant HUTCHMED Amneal Pharmaceuticals Organon & Co. Catalyst Pharmaceuticals (NASDAQ:CPRX) and Anavex Life Sciences (NASDAQ:AVXL) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, community ranking, institutional ownership and profitability. Does the media favor CPRX or AVXL? In the previous week, Anavex Life Sciences had 4 more articles in the media than Catalyst Pharmaceuticals. MarketBeat recorded 14 mentions for Anavex Life Sciences and 10 mentions for Catalyst Pharmaceuticals. Catalyst Pharmaceuticals' average media sentiment score of 1.15 beat Anavex Life Sciences' score of 0.65 indicating that Catalyst Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Catalyst Pharmaceuticals 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Anavex Life Sciences 3 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer CPRX or AVXL? Catalyst Pharmaceuticals received 62 more outperform votes than Anavex Life Sciences when rated by MarketBeat users. Likewise, 75.11% of users gave Catalyst Pharmaceuticals an outperform vote while only 74.92% of users gave Anavex Life Sciences an outperform vote. CompanyUnderperformOutperformCatalyst PharmaceuticalsOutperform Votes50475.11% Underperform Votes16724.89% Anavex Life SciencesOutperform Votes44274.92% Underperform Votes14825.08% Do insiders & institutionals believe in CPRX or AVXL? 79.2% of Catalyst Pharmaceuticals shares are held by institutional investors. Comparatively, 31.5% of Anavex Life Sciences shares are held by institutional investors. 10.4% of Catalyst Pharmaceuticals shares are held by company insiders. Comparatively, 11.4% of Anavex Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more risk and volatility, CPRX or AVXL? Catalyst Pharmaceuticals has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500. Comparatively, Anavex Life Sciences has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Which has higher valuation and earnings, CPRX or AVXL? Catalyst Pharmaceuticals has higher revenue and earnings than Anavex Life Sciences. Anavex Life Sciences is trading at a lower price-to-earnings ratio than Catalyst Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCatalyst Pharmaceuticals$534.65M5.55$71.41M$1.5715.49Anavex Life SciencesN/AN/A-$43M-$0.55-14.15 Is CPRX or AVXL more profitable? Catalyst Pharmaceuticals has a net margin of 31.01% compared to Anavex Life Sciences' net margin of 0.00%. Catalyst Pharmaceuticals' return on equity of 40.79% beat Anavex Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Catalyst Pharmaceuticals31.01% 40.79% 34.87% Anavex Life Sciences N/A -37.50%-34.08% Do analysts rate CPRX or AVXL? Catalyst Pharmaceuticals presently has a consensus target price of $32.29, indicating a potential upside of 32.75%. Anavex Life Sciences has a consensus target price of $44.00, indicating a potential upside of 465.55%. Given Anavex Life Sciences' stronger consensus rating and higher probable upside, analysts clearly believe Anavex Life Sciences is more favorable than Catalyst Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Catalyst Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Anavex Life Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 SummaryCatalyst Pharmaceuticals beats Anavex Life Sciences on 12 of the 17 factors compared between the two stocks. Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVXL vs. The Competition Export to ExcelMetricAnavex Life SciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$664.19M$2.93B$5.35B$8.38BDividend YieldN/A1.72%5.22%4.10%P/E Ratio-14.1530.5026.8419.71Price / SalesN/A400.15391.39116.98Price / CashN/A168.6838.2534.62Price / Book5.483.286.794.50Net Income-$43M-$72.17M$3.23B$248.18M7 Day Performance-4.77%4.28%4.07%1.14%1 Month Performance-11.19%7.62%12.52%15.20%1 Year Performance78.85%-28.15%16.83%6.56% Anavex Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVXLAnavex Life Sciences3.7455 of 5 stars$7.78+3.3%$44.00+465.6%+70.0%$664.19MN/A-14.1540CPRXCatalyst Pharmaceuticals4.6121 of 5 stars$23.83+2.0%$32.29+35.5%+45.9%$2.91B$491.73M20.1980Positive NewsMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730PTGXProtagonist Therapeutics3.405 of 5 stars$45.27+5.4%$65.44+44.6%+49.1%$2.80B$207.80M17.02120News CoveragePositive NewsAnalyst ForecastMTSRMetseraN/A$26.38+10.5%$47.00+78.2%N/A$2.77BN/A0.0081XENEXenon Pharmaceuticals3.2381 of 5 stars$35.85+2.4%$56.22+56.8%-22.2%$2.75B$9.43M-12.71210Positive NewsAnalyst DowngradeHigh Trading VolumeMLTXMoonLake Immunotherapeutics3.2957 of 5 stars$40.18+4.4%$80.50+100.3%+4.2%$2.57BN/A-31.152Positive NewsAnalyst UpgradeIMVTImmunovant2.7146 of 5 stars$14.55+3.8%$38.33+163.5%-51.4%$2.47BN/A-5.55120Positive NewsHCMHUTCHMED2.2843 of 5 stars$13.92-2.0%$19.00+36.5%-33.9%$2.43B$630.20M0.001,760Positive NewsGap DownAMRXAmneal Pharmaceuticals3.2515 of 5 stars$7.60+2.6%$11.50+51.3%+10.3%$2.36B$2.83B-11.187,600OGNOrganon & Co.4.7569 of 5 stars$8.69+0.0%$18.00+107.1%-59.8%$2.26B$6.29B2.6110,000High Trading Volume Related Companies and Tools Related Companies CPRX Alternatives MOR Alternatives PTGX Alternatives MTSR Alternatives XENE Alternatives MLTX Alternatives IMVT Alternatives HCM Alternatives AMRX Alternatives OGN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVXL) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVXL Stock Free AVXL Stock Alerts